SXTC · NASDAQ
China SXT Pharmaceuticals (SXTC) Stock Price & Fundamentals
China SXT Pharmaceuticals (SXTC) closed at $1,004.60 on Oct 9, 2026, up 0.84% from the previous close of $996.28.
Share price, past year
1Y +33.32%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,004.60 |
| Sep 30, 2026 | $1,008.28 |
| Aug 31, 2026 | $971.62 |
| Jul 31, 2026 | $910.89 |
| Jun 30, 2026 | $928.82 |
| May 29, 2026 | $903.12 |
| Apr 30, 2026 | $831.29 |
| Mar 31, 2026 | $798.36 |
| Feb 27, 2026 | $864.11 |
| Jan 30, 2026 | $854.48 |
| Dec 31, 2025 | $815.77 |
| Nov 28, 2025 | $821.12 |
| Oct 31, 2025 | $782.12 |
Key statistics
- Market cap
- $962.48M
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 958.1K
- Dividend yield
- —
- 52-week range
- $753.54 – $1,039.71
China SXT Pharmaceuticals's market cap is $962.48M, based on a share price of $1,004.60 and 958.1K shares outstanding as of Mar 31, 2026.
Financials
China SXT Pharmaceuticals reported revenue of $1.14M for fiscal 2026, down 34.63% from fiscal 2025.
China SXT Pharmaceuticals reported a net loss of $6.21M in fiscal 2026.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Mar 31, 2026 | $1.14M | −34.6% | −$6.21M | −545.2% | −$9.13 | — |
| FY2025ended Mar 31, 2025 | $1.74M | −9.7% | −$3.30M | −189.8% | −$348.17 | −$2.35M |
| FY2024ended Mar 31, 2024 | $1.93M | −2.2% | −$3.10M | −160.7% | −$4,285.66 | −$1.94M |
| FY2023ended Mar 31, 2023 | $1.97M | −24.2% | −$5.93M | −301.0% | −$177.84 | — |
| FY2022ended Mar 31, 2022 | $2.60M | −45.5% | −$5.74M | −220.4% | −$137.92 | — |
| FY2021ended Mar 31, 2021 | $4.78M | −7.5% | −$2.75M | −57.5% | −$3.82 | — |
| FY2020ended Mar 31, 2020 | $5.16M | −26.4% | −$10.29M | −199.3% | $1.66 | $803.41K |
| FY2019ended Mar 31, 2019 | $7.01M | −0.1% | $1.54M | 22.0% | $0.075 | −$296.63K |
| FY2018ended Mar 31, 2018 | $7.02M | +43.8% | $1.19M | 16.9% | $0.059 | $1.48M |
| FY2017ended Mar 31, 2017 | $4.88M | — | $1.19M | 24.3% | $0.059 | $113.87K |
Company profile
- Name
- China SXT Pharmaceuticals, Inc.
- Ticker
- SXTC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 178 Taidong Road North, Taizhou
- Incorporated in
- D8
- Fiscal year ends
- March
- SEC CIK
- 0001723980
Frequently asked questions
What is China SXT Pharmaceuticals's stock price?
China SXT Pharmaceuticals (SXTC) closed at $1,004.60 on Oct 9, 2026, up 0.84% from the previous close of $996.28.
What is China SXT Pharmaceuticals's market cap?
China SXT Pharmaceuticals's market cap is $962.48M, based on a share price of $1,004.60 and 958.1K shares outstanding as of Mar 31, 2026.
How much revenue does China SXT Pharmaceuticals make?
China SXT Pharmaceuticals reported revenue of $1.14M for fiscal 2026, down 34.63% from fiscal 2025.
Sources and methodology
Fundamentals come from China SXT Pharmaceuticals, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures